Atara Biotherapeutics
Atara Biotherapeutics's Overview
Atara Biotherapeutics, Inc. is a pioneering allogeneic T-cell immunotherapy company focused on developing transformative therapies for patients with serious medical conditions including solid tumors, hematologic cancers, and autoimmune diseases. Leveraging their novel allogeneic Epstein-Barr virus (EBV) T-cell platform, Atara aims to deliver readily available treatments to patients from healthy donor T-cells. Their leading candidate, tabelecleucel (tab-cel®), is in development for EBV-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Where is Atara Biotherapeutics's Headquarters?
HQ Function
The South San Francisco headquarters serves as the central hub for Atara's corporate strategy, executive leadership, administrative functions, and clinical development oversight.
Notable Features:
Modern office spaces designed to foster collaboration and innovation, likely equipped with advanced communication technology to connect with global teams and research sites.
Work Culture:
The work culture at Atara Biotherapeutics emphasizes scientific rigor, patient-centricity, collaboration, and innovation. Employees are driven by the mission to develop life-changing therapies for patients with limited treatment options.
HQ Significance:
Its location in the San Francisco Bay Area provides access to a rich ecosystem of talent, research institutions, and potential partners, crucial for a biotech company.
Values Reflected in HQ: The headquarters' design and location likely reflect Atara's commitment to innovation, excellence, and being at the forefront of T-cell immunotherapy research and development.
Location:
While headquartered and with primary operations in the United States (California and Colorado), Atara Biotherapeutics conducts clinical trials in multiple countries across North America, Europe, and potentially other regions. Their global presence is primarily driven by their clinical development programs and collaborations with international research institutions and healthcare providers to bring their innovative therapies to patients worldwide. They also have a presence in Zug, Switzerland, for European operations.
Street Address:
611 Gateway Blvd, Suite 900
City:
South San Francisco
State/Province:
CA
Country:
USA
Atara Biotherapeutics's Global Presence
Thousand Oaks, CA, USA
Address: One Atara Bio Way, Thousand Oaks, CA 91320
Leverages the strong biotech talent pool in Southern California and supports preclinical research, process development, and operational activities.
Aurora, CO, USA
Address: Atara Cell Therapy Manufacturing Facility (ATOM), 14100 E. 35th Place, Aurora, CO 80011
Establishes in-house manufacturing capabilities, ensuring quality control and supply chain reliability for their innovative cell therapies. Provides access to a skilled manufacturing workforce.
Buying Intent Signals for Atara Biotherapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Atara Biotherapeutics
As of April 2025, Atara Biotherapeutics' leadership includes:
Investors of Atara Biotherapeutics
Atara Biotherapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Atara Biotherapeutics has seen key appointments and departures in its executive team over the past year, reflecting strategic shifts and a focus on advancing its pipeline and commercial readiness. Notable changes include appointments in medical and technical leadership and a departure in the commercial team.
Departures
New Appointments:
Technology (Tech Stack) used by Atara Biotherapeutics
Discover the tools Atara Biotherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Atara Biotherapeutics Email Formats and Examples
Atara Biotherapeutics commonly uses the email format of first initial followed by the last name. Other formats might exist but this is the most frequently observed pattern.
[first_initial][last]@atarabio.com
Format
jdoe@atarabio.com
Example
85%
Success rate
News and media
Atara Biotherapeutics Press Release • January 4, 2024
Atara Biotherapeutics news title: Atara Biotherapeutics Announces Strategic Update Prioritizing Allogeneic CAR T Development and Extending Cash Runway
Atara announced a strategic update to prioritize ATA3219 (allogeneic CD19 CAR T) and ATA3431 (allogeneic CD20 CAR T) programs. The company will reduce its workforce by approximately 25% and streamline operations to extend cash runway into Q2 2026. This includes wind-down of tab-cel® and ATA188 activities in the U.S. while continuing to seek a commercialization partner for tab-cel® in the U.S....more
Atara Biotherapeutics Press Release • November 2, 2023
Atara Biotherapeutics news title: Atara Biotherapeutics Appoints Danelle James, M.D., M.A.S., as Chief Medical Officer
Atara Biotherapeutics announced the appointment of Danelle James, M.D., M.A.S., as Executive Vice President, Chief Medical Officer. Dr. James brings extensive experience in global clinical development and medical affairs in oncology and rare diseases....more
European Medicines Agency (EMA) • October 24, 2023
Atara Biotherapeutics news title: European Commission Grants Marketing Authorization for Ebvallo™ (tabelecleucel) for Patients with EBV+ PTLD
The European Commission granted Marketing Authorization for Ebvallo™ (tabelecleucel) as a monotherapy for the treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy. For solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate. This was a major regulatory milestone for the company. (Note: Commercialization partner is Pierre Fabre in Europe)....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Atara Biotherapeutics, are just a search away.